| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 63.07B | 84.24B | 59.20B | 47.77B | 44.59B | 45.44B |
| Gross Profit | 13.77B | 18.00B | 13.21B | 11.36B | 8.68B | 8.31B |
| EBITDA | 7.90B | 10.08B | 7.76B | 8.37B | 5.04B | 4.17B |
| Net Income | 5.13B | 7.55B | 4.88B | 5.40B | 3.04B | 2.55B |
Balance Sheet | ||||||
| Total Assets | 63.48B | 78.09B | 66.17B | 63.17B | 54.48B | 52.49B |
| Cash, Cash Equivalents and Short-Term Investments | 10.77B | 9.03B | 10.82B | 15.18B | 13.12B | 11.23B |
| Total Debt | 3.30B | 5.50B | 3.30B | 3.30B | 3.30B | 3.30B |
| Total Liabilities | 25.38B | 33.16B | 27.94B | 28.59B | 24.15B | 25.18B |
| Stockholders Equity | 38.09B | 44.93B | 38.23B | 34.58B | 30.32B | 27.31B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.90B | -4.39B | -817.00M | 82.00M | 4.18B |
| Operating Cash Flow | 0.00 | 1.80B | -3.31B | 1.36B | 996.00M | 5.12B |
| Investing Cash Flow | 0.00 | -3.53B | 43.00M | 1.37B | 1.35B | -558.00M |
| Financing Cash Flow | 0.00 | -181.00M | -1.05B | -854.00M | -533.00M | -512.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥985.46B | 60.50 | 6.61% | 1.58% | -1.47% | -19.46% | |
75 Outperform | ¥251.12B | 18.20 | 9.02% | 3.11% | 9.57% | 40.16% | |
74 Outperform | ¥84.60B | 10.90 | 16.37% | 2.79% | 42.29% | 55.00% | |
73 Outperform | ¥703.48B | 24.82 | ― | 1.43% | 8.81% | 17.58% | |
64 Neutral | ¥143.42B | 15.69 | 12.54% | 1.84% | 17.17% | 33.30% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥227.01B | 20.35 | ― | 2.41% | 5.68% | -49.64% |